Control of both myeloid cell infiltration and angiogenesis by ccr1 promotes liver cancer metastasis development in mice

Neoplasia (United States)

Volumn 15, Issue 6, 2013, Pages 641-648

  Rodero, Mathieu Paul ^a   Auvynet, Constance ^a   Poupel, Lucie ^a   Combadière, Behazine ^a,b   Combadière, Christophe ^a,b  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CHEMOKINE RECEPTOR CCR1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LECTIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LIVER CANCER; METASTASIS; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

EID: 84878639319     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.121866     Document Type: Article

References (33)

1. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50-56.
2. Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL, Zona GL, Spaziante R, Florio T, and Schettini G (2003). Stromal cell-derived factor 1α stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 63, 1969-1974.
3. Strieter RM, Kunkel SL, Elner VM, Martonyi CL, Koch AE, Polverini PJ, and Elner SG (1992). Interleukin-8. A corneal factor that induces neovascularization. Am J Pathol 141, 1279-1284.
4. Balkwill F and Mantovani A (2001). Inflammation and cancer: back to Virchow? Lancet 357, 539-545.
5. Lewis CE and Pollard JW (2006). Distinct role of macrophages in different tumor microenvironments. Cancer Res 66, 605-612.
6. Loercher AE, Nash MA, Kavanagh JJ, Platsoucas CD, and Freedman RS (1999). Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells. J Immunol 163, 6251-6260.
7. Mantovani A, Allavena P, and Sica A (2004). Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. Eur J Cancer 40, 1660-1667.
8. Leek RD and Harris AL (2002). Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 7, 177-189.
9. Lin EY, Nguyen AV, Russell RG, and Pollard JW (2001). Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193, 727-740.
10. Kitamura T, Kometani K, Hashida H, Matsunaga A, Miyoshi H, Hosogi H, Aoki M, Oshima M, Hattori M, Takabayashi A, et al. (2007). SMAD4- deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion. Nat Genet 39, 467-475.
11. Kitamura T, Fujishita T, Loetscher P, Revesz L, Hashida H, Kizaka-Kondoh S, Aoki M, and Taketo MM (2010). Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model. Proc Natl Acad Sci USA 107, 13063-13068.
12. Yang X, Lu P, Fujii C, Nakamoto Y, Gao JL, Kaneko S, Murphy PM, and Mukaida N (2006). Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression. Int J Cancer 118, 1869-1876.
13. Combadiere C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, Merval R, Proudfoot A, Tedgui A, and Mallat Z (2008). Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6Chi and Ly6Clo monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 117, 1649-1657.
14. van Deventer HW, O'Connor W Jr, Brickey WJ, Aris RM, Ting JP, and Serody JS (2005). C-C chemokine receptor 5 on stromal cells promotes pulmonary metastasis. Cancer Res 65, 3374-3379.
15. Bordignon C, Carlo-Stella C, Colombo MP, De Vincentiis A, Lanata L, Lemoli RM, Locatelli F, Olivieri A, Rondelli D, Zanon P, et al. (1999). Cell therapy: achievements and perspectives. Haematologica 84, 1110-1149.
16. Lazennec G and Richmond A (2010). Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 16, 133-144.
17. Rodero M, Marie Y, Coudert M, Blondet E, Mokhtari K, Rousseau A, Raoul W, Carpentier C, Sennlaub F, Deterre P, et al. (2008). Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma. J Clin Oncol 26, 5957-5964.
18. Rodero M, Rodero P, Descamps V, Lebbe C, Wolkenstein P, Aegerter P, Vitoux D, Basset-Seguin N, Dupin N, Grandchamp B, et al. (2007). Melanoma susceptibility and progression: association study between polymorphisms of the chemokine (CCL2) and chemokine receptors (CX3CR1, CCR5). J Dermatol Sci 46, 72-76.
19. Wang CL, Sun BS, Tang Y, Zhuang HQ, and Cao WZ (2009). CCR1 knockdown suppresses human non-small cell lung cancer cell invasion. J Cancer Res Clin Oncol 135, 695-701.
20. Wu X, Fan J, Wang X, Zhou J, Qiu S, Yu Y, Liu Y, and Tang Z (2007). Downregulation of CCR1 inhibits human hepatocellular carcinoma cell invasion. Biochem Biophys Res Commun 355, 866-871.
21. Menu E, De Leenheer E, De Raeve H, Coulton L, Imanishi T, Miyashita K, Van Valckenborgh E, Van Riet I, Van Camp B, Horuk R, et al. (2006). Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model. Clin Exp Metastasis 23, 291-300.
22. Lu P, Nakamoto Y, Nemoto-Sasaki Y, Fujii C, Wang H, Hashii M, Ohmoto Y, Kaneko S, Kobayashi K, and Mukaida N (2003). Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas. Am J Pathol 162, 1249-1258.
23. Geissmann F, Jung S, and Littman DR (2003). Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82.
24. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, van Rooijen N, et al. (2007). Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117, 185-194.
25. Iida N, Nakamoto Y, Baba T, Nakagawa H, Mizukoshi E, Naito M, Mukaida N, and Kaneko S (2010). Antitumor effect after radiofrequency ablation of murine hepatoma is augmented by an active variant of CC chemokine ligand 3/ macrophage inflammatory protein-1α. Cancer Res 70, 6556-6565.
26. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, and Weinberg RA (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348.
27. Vizoso FJ, Gonzalez LO, Corte MD, Rodriguez JC, Vazquez J, Lamelas ML, Junquera S, Merino AM, and Garcia-Muniz JL (2007). Study of matrix metalloproteinases and their inhibitors in breast cancer. Br J Cancer 96, 903-911.
28. Thomas RA, Pietrzak DC, Scicchitano MS, Thomas HC, McFarland DC, and Frazier KS (2009). Detection and characterization of circulating endothelial progenitor cells in normal rat blood. J Pharmacol Toxicol Methods 60, 263-274.
29. Hwang J, Son KN, Kim CW, Ko J, Na DS, Kwon BS, Gho YS, and Kim J (2005). Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis. Cytokine 30, 254-263.
30. Suffee N, Hlawaty H, Meddahi-Pelle A, Maillard L, Louedec L, Haddad O, Martin L, Laguillier C, Richard B, Oudar O, et al. (2012). RANTES/CCL5- induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans. Angiogenesis 15, 727-744.
31. Brooke G, Tong H, Levesque JP, and Atkinson K (2008). Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta. Stem Cells Dev 17, 929-940.
32. Huang J, Zhang Z, Guo J, Ni A, Deb A, Zhang L, Mirotsou M, Pratt RE, and Dzau VJ (2010). Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circ Res 106, 1753-1762.
33. Cochain C, Rodero MP, Vilar J, Recalde A, Richart A, Loinard C, Zouggari Y, Guerin C, Duriez M, Combadiere B, et al. (2010). Regulation of monocyte subsets systemic levels by distinct chemokine receptors controls postischemic neovascularization. Cardiovasc Res 88, 186-195.